Impact of antibiotic treatment on immune-checkpoint blockade efficacy in advanced non-squamous non-small cell lung cancer

Despite durable responses from immune-checkpoint blockade (ICB) in a subset of patients with advanced non-small cell lung cancer (NSCLC), the majority of patients do not derive benefit from this treatment. In this analysis we evaluated the impact of concomitant administration of antibiotics during i...

Celý popis

Podrobná bibliografia

Vydané v:	Oncotarget Ročník 9; číslo 23; s. 16512
Hlavní autori:	Huemer, Florian, Rinnerthaler, Gabriel, Westphal, Theresa, Hackl, Hubert, Hutarew, Georg, Gampenrieder, Simon Peter, Weiss, Lukas, Greil, Richard
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States 27.03.2018
Predmet:	overall survival immune-checkpoint blockade non-squamous non-small cell lung cancer antibiotics progression-free survival
ISSN:	1949-2553, 1949-2553
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!